RSSCategory: Laboratory Compliance

Will Not Using Image Analysis in Pathology be Perceived as Irresponsible? 

| February 1, 2017 | 0 Comments

Originally published by Simon Häger, Product Manager Sectra Digital Pathology Solution at Sectra.com.  It is hard to argue with any of the points raised here by Simon. No doubt image analysis will enable what we do to do it better. More quantitative analysis. Better, faster, cheaper, more accurate. Image analysis and tele-consultation have been and will […]

Continue Reading

Understanding Reimbursement Changes in the U.S. and What They Mean to Your Anatomic Pathology (AP) Laboratory

| January 24, 2017 | 0 Comments

Save your spot to learn more about the effects of reimbursement changes in the US on the anatomic pathology market and in your laboratory You are invited to our next complimentary webinar – January 24, 2017 Understanding Reimbursement Changes in the U.S. and What They Mean to Your Anatomic Pathology (AP) Laboratory The United States […]

Continue Reading

PRESS RELEASE: Innovative Anatomic Pathology Groups Use New Strategies to Increase Revenue and Maximize Pathologists’ Income Despite Unprecedented Price Cuts, Exclusionary Narrow Networks and Tougher Payer Audits

| January 23, 2017 | 0 Comments

PRESS RELEASE   THE DARK REPORT 21806 Briarcliff Dr. Spicewood, Texas 78669 512-264-7103 o 512-264-0969 f   FOR IMMEDIATE RELEASE Media Contact: Chris Garcia chris@darkreport.com   AUSTIN, Texas (January 16, 2017) It is the worst financial environment for the anatomic pathology profession in decades. Across the nation, pathology groups are coping with falling revenue, rising […]

Continue Reading

Register Now for CAP Webinar on HER2 Testing in Gastroesophageal Adenocarcinoma

| January 13, 2017 | 0 Comments

  In 2010, results of a phase 3 randomized controlled trial showed that targeted therapy directed against HER2 statistically significantly prolonged overall survival compared with chemotherapy alone in patients with HER2–positive advanced GEA. Because there are important differences in HER2 expression, scoring, and outcomes in GEA relative to breast carcinoma, the need for guideline recommendations […]

Continue Reading

To Sign Out or Not to Sign Out? Part 2: The Fax Machine

| January 13, 2017 | 0 Comments

I received a lot of feedback offline about Part 1 of this post (see: “To Sign Out or Not to Sign Out? Part 1” ) from a number of pathologists echoing my sentiments on the issue of turnaround time in general and needs/expectations from clinicians and patients about getting their results in a timely manner. […]

Continue Reading

To Sign Out or Not to Sign Out? Part 1

| December 27, 2016 | 0 Comments

That is the question. Every year. Around the holidays or three-day weekends. Normally biopsies or surgical specimens collected the day before are reviewed the next day. In a majority of cases, the case can be “signed out” meaning your opinion goes into a surgical pathology report and becomes part of the medical record. New malignancies, […]

Continue Reading

FDA Delays Final Guidance on Regulating LDTs

| November 25, 2016 | 0 Comments

medpagetoday.com posted a brief but concise article earlier this week on the issue of FDA regulating laboratory developed tests (LDTs). While the FDA has had the ability to regulate these tests since 1976, largely once regarded as “simple and scarce” as the article mentions, not before a draft guidance issued in 2014 has the FDA […]

Continue Reading

Mikroscan and QualityStar® Partner To Address Subspecialty Case Review In Community Pathology Practices

| October 25, 2016 | 0 Comments

Enabling Economical Digital Pathology Transformation for Next-gen Diagnostic Accuracy in AP San Diego, CA — October 25, 2016 — Mikroscan Technologies, Inc. Mikroscan announced today it has entered into an agreement with QualityStar, LLC., a quality analytics and case review subscription service for Anatomic Pathology, to market its cloud-based and confidential case review to help […]

Continue Reading

Multi-Center Clinical Validation Study by Philips to be Submitted to FDA in Support of Expanded Indications for Use for Philips IntelliSite Digital Pathology Solution in the U.S.

| October 24, 2016 | 0 Comments

Great news from Philips who announced on October 21st their completion of a glass versus digital concordance study to be submitted to FDA.  The press release mentions 2,000 cases with approximately 16,000 reads. The press release goes on to say that the final discordance rate was 1%. Philips will submit the results of the study along […]

Continue Reading

Case Study using HALO™ and STRATA™: Biomarkers of Anti-Tumor Immune Activity Associate with Survival in Melanoma

| September 19, 2016 | 0 Comments

Wednesday September 28th | 8 AM PDT | 11 AM EDT | 4 PM BST Presenters Dr. Tricia Cottrell, Johns Hopkins Medical School  Vlado Ovtcharov, Indica Labs PD-L1 expression in the tumor microenvironment can be both prognostic and predictive.  PD-L1 expression is often a marker of an ongoing CD8+ cytotoxic T-cell-mediated anti-tumor immune response, and thus, […]

Continue Reading

Inspirata Acquires Precision Medicine Network, Inc. and the ‘Crosswalk’ Platform to Bridge the Gap Between Digital Pathology and Molecular Oncology

| September 13, 2016 | 0 Comments

“Crosswalk Insight™: Oncology” enhances Inspirata’s Digital Pathology Cockpit by providing access to Genomic Profiles, FDA-Approved Targeted Therapies, Immunotherapies and Clinical Trials to enable pathologists to make more precise diagnostic and therapeutic decisions. Tampa, FL, September 13, 2016 – Cancer diagnostics and digital pathology workflow solution provider Inspirata, Inc. announced today that it has acquired the assets […]

Continue Reading

QualityStar, Diagnostic Quality Assurance® PSO, First Anatomic Pathology QA Program To Attain Patient Safety Organization (PSO) Listing by HHS

| August 24, 2016 | 0 Comments

DIAGNOSTIC QUALITY ASSURANCE® The Agency for Healthcare Research and Quality Assurance (AHRQ) has approved the Diagnostic Quality Assurance ® (DQA) listing as a Patient Safety Organization (PSO) by the Secretary of the Department of Health and Human Services (HHS). Diagnostic Quality Assurance® PSO is a component entity of QualityStar, LLC (www.qualitystar.net), and is the first […]

Continue Reading

Pathology 2.0 Comes of Age: Recommendations for Protecting Privacy While Motivating Education

| August 10, 2016 | 0 Comments

There is an interesting article in this month’s AMA Journal of Ethics by Drs. Crane and Gardner on the use of pathology images in social media. The authors introduce the article in their abstract as “There is a rising interest in the use of social media by pathologists. However, the use of pathology images on […]

Continue Reading